Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Monday, 31 July 2017

Corbion reports transactions under its current share buyback program

Corbion    

Published: 07:00 CEST 31-07-2017 /GlobeNewswire /Source: Corbion / : CRBN /ISIN: NL0010583399

Corbion reports transactions under its current share buyback program

 

Corbion has repurchased 38,500 of its own common shares in the period from July 24, 2017 up to and including July 28, 2017 at an average price of € 27.33 per share. The consideration of the repurchase was € 1.05 million.

 

Corbion's current share buyback program commenced on 18 April 2017, and details are available on our website at http://www.corbion.com/investor-relations/shareholder-information/share-buyback-program

 

This regular update of the transactions conducted under the share buyback program is to be made public under the EU Market Abuse Regulation.

 

 

   

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

 

Background information:
Corbion is the global market leader in lactic acid and lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals and vitamins. We develop sustainable solutions to improve the quality of life for people today and generations to come. For over 100 years, we have been uncompromising in our commitment to safety, quality and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting edge technologies work for them. Our solutions help differentiate products in markets such as food, home & personal care, pharmaceuticals, medical devices and bioplastics. In 2016, Corbion generated annual sales of € 911.3 million and had a workforce of 1,684 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com

 



Share buyback reporting_2017 july 28_ENG



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: Corbion, P.O. Box 349, Amsterdam 1000 AH, The Netherlands
If you would like to unsubscribe and stop receiving these e-mails click here.